|
|
Home > Healthcare > Biotechnology > Cell/Tissue Engineering
New Options for Treating Neurological Disease: Stem Cell Therapy
|
| Published Date:
December 2006
Published By:
Decision Resources
Page Count:
25
Order Code:
R55-322
|
|
|
|
Price reduced due to age.
Stem cell therapy development is challenged by controversy, intellectual property issues, and a
high failure rate. Despite these challenges, stem cell therapy presents some of the most promising
options for hard-to-treat and highly degenerative neurological diseases.
Get the Answers You Need to Shape Your Strategy
Stem cell therapy holds vast potential for treating degeneration or injury in areas of the body that
are incapable of autonomous healing, such as the central nervous system (CNS). How can stem
cells boost healing in the CNS? What are the limitations of these therapies in the CNS? What
scientific and regulatory roadblocks exist for developing stem cell therapies for the CNS?
Several manufacturers are investigating stem cell therapies to treat neurological disease. What
are the different approaches for developing these therapies? What value do different stem cell
therapies offer, and what challenges do they face? How might these agents impact the different
disease markets?
Stem cell therapies may represent the first true disease-modifying therapies for multiple
neurological diseases, but their success will depend on many factors, including ethics, clinical
trial design, and safety concerns. How are ethics affecting stem cell design? What can we expect
from future stem cell clinical trials? Which stem cell therapies are likely to offer the best safety
profiles?
Scope
Stem cell introduction: stages of stem cell differentiation, comparison of stem cell types,
history of stem cell development.
Value of stem cells for neurological diseases: benefi ts and limitations of stem cells and
their therapeutic value for multiple neurological indications, including Alzheimer’s disease
and Parkinson’s disease.
Emerging stem cell therapies for neurological uses: discussion of multiple companies’
initiatives into developing neurological stem cell therapies.
Outlook: hurdles for stem cell therapy development, discussion of which stem cell
therapies are more likely to succeed.
|
Similar Products
• Regenerative Medicines: Bone and Joint Applications
Published Oct 2009 by BCC Research
• Stem Cell Markets
Published Jun 2009 by Trimark Publications
• Growth Factors (Blood And Tissue)
Published Oct 2008 by Global Industry Analysts
• Advances in Replacement Organs and Tissue Engineering (Technical Insights)
Published Sep 2008 by Frost & Sullivan
• Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
Published Mar 2008 by Kalorama Information
• Tissue Engineering and Cell Transplantation: Technologies, Opportunities, and Evolving Markets in the U.S.
Published Jul 2007 by Medtech Insight
• Stem Cell - Analysis and Market Forecasts, 2006-2016
Published Mar 2007 by RRY Publications
• Tissue Engineering & Stem Cell Technology Report 2007
Published Feb 2007 by Visiongain
• Hitting the Bull's-Eye with Your Eyes Closed: The Stem Cell Magic Bullet
Published Dec 2006 by IDC
|
|
|
|
0 items
